|
|
Volumn 12, Issue 1, 2001, Pages 105-108
|
|
Cyclophosphamide, adriamycin and dexamethasone (CAD) is a highly effective therapy for patients with advanced multiple myeloma
a
b
a
|
|
Author keywords
Adriamycin; Chemotherapy; Cyclophosphamide; Dexametasone; Multiple myeloma
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
ALKYLATING AGENT;
ASPARTATE AMINOTRANSFERASE;
BETA 2 MICROGLOBULIN;
BILIRUBIN;
C REACTIVE PROTEIN;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
IMMUNOGLOBULIN A;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN LIGHT CHAIN;
IMMUNOGLOBULIN M;
LACTATE DEHYDROGENASE;
M PROTEIN;
MELPHALAN;
PREDNISONE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CANCER STAGING;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CLASSIFICATION;
DISEASE SEVERITY;
DOSE TIME EFFECT RELATION;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG TOLERABILITY;
FEBRILE NEUTROPENIA;
FEMALE;
GASTROINTESTINAL TOXICITY;
HAIR LOSS;
HUMAN;
INFECTION;
KIDNEY FAILURE;
MALE;
MULTIPLE MYELOMA;
NAUSEA;
NEUTROPENIA;
PRIORITY JOURNAL;
REMISSION;
STEM CELL TRANSPLANTATION;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADMINISTRATION, ORAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DISEASE PROGRESSION;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
NEUTROPENIA;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
|
EID: 0035136840
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1008362107080 Document Type: Article |
|
Times cited : (7)
|
|
References (22)
|
